Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 2, 2014, Pages

  Rutten, Marianne J ^a   Leeflang, Mariska M G ^a   Kenter, Gemma G ^a   Mol, Ben Willem J ^b   Buist, Marrije ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BRAIN HEMORRHAGE; CANCER DIAGNOSIS; CANCER SURGERY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FALSE POSITIVE RESULT; HUMAN; LAPAROSCOPY; OPEN SURGERY; OVARIECTOMY; OVARY CANCER; PREDICTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT INDICATION; VALIDATION STUDY; ADJUVANT CHEMOTHERAPY; FEMALE; LAPAROSCOPE; MINIMAL RESIDUAL DISEASE; OVARY TUMOR; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR VOLUME;

CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LAPAROSCOPES; LAPAROSCOPY; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR BURDEN; VALIDATION STUDIES AS TOPIC;

EID: 84904303444     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009786.pub2     Document Type: Review

References (35)

1. Angioli R, Palaia I, Zullo MA, Muzii L, Manci N, Calcagno M, et al.Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecologic Oncology 2006;100(3):455-61.
2. Brun JL, Rouzier R, Uzan S, Darai E. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecologic Oncology 2008;110(3):354-9.
3. Brun JL, Rouzier R, Selle F, Houry S, Uzan S, Darai E. Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy. BMC Cancer 2009;9:171.
4. Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. International Journal of Gynecological Cancer 2006;16 Suppl 1:35-40.
5. Fagotti A, Fanfani F, Ludovisi M, Lo Voi R, Bifulco G, Testa AC, et al.Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecologic Oncology 2005;96(3):729-35.
6. Fagotti A, Ferrandina G, Fanfani F, Garganese G, Vizzielli G, Carone V, et al.Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. American Journal of Obstetrics & Gynecology 2008;199(6):642-6.
7. Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, Van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecologic Oncology 1998;71(3):431-6.
8. Batka M, Graf AH, Steiner H, Staudach A. [Laparotomy vs. pelviscopy in adnexa processes--preoperative assessment, therapy planning and histology]. [German]. Gynakologisch-Geburtshilfliche Rundschau 1993;33 Suppl 1:41-3.
9. Bristow RE. Predicting "unresectable" ovarian cancer: Taking aim at a moving target. Gynaecologic Oncology 2006;100:449-50.
10. Bruhat MA, Dal Soglio I, Mage G, Manhes H. Coelioscopy and ovarian cancer. Gynecologie 1981;32:191-6.
11. Brun J, Rouzier R, Uzan S, Darai E. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score. International Journal of Gynecology and Obstetrics 2009;Conference: 19th FIGO World Congress of Gynecology and Obstetrics Cape Town South Africa. Conference Start: 20091004 Conference End: 20091009. Conference Publication::S135.
12. Dagnini G, Marin G, Caldironi MW, Piccigallo E, Miola E. Laparoscopy in staging, follow-up, and restaging of ovarian carcinoma. Gastrointestinal Endoscopy 1987;33(2):80-3.
13. Fagotti A, Ferrandina G, Fanfani F, Ercoli A, Lorusso D, Rossi M, et al.A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Annals of Surgical Oncology 2006;13(8):1156-61.
14. Gurrea M, Fuster S, Rodriguez E, Ruiz F, Domingo S, Pellicer A. Inclusion of diagnostic laparoscopy in the advanced ovarian cancer work algorithm. Gynecological Surgery 2010;Conference: 19th Annual Congress of the European Society for Gynaecological Endoscopy, ESGE Barcelona Spain. Conference Start: 20100929 Conference End: 20101002. Conference Publication::S41.
15. Nezhat FR, DeNoble SM, Liu CS, Cho JE, Brown DN, Chuang L, et al.The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers. Journal of the Society of Laparoendoscopic Surgeons 2010;14(2):155-68.
16. Vergote I. Controversies in surgery in ovarian cancer - What is its real role?. European Journal of Cancer, Supplement 2003;1:115-25.
17. Rutten MJ, Gaarenstroom KN, Van Gorp T, van Meurs HS, Arts HJ, Bossuyt PM, et al.Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study. BMC Cancer 2012;12:31. [PUBMED: 22264278]
18. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Journal of Clinical Oncology 2002;20(5):1248-59. [MEDLINE: 11870167]
19. Chi DS, Abu-Rustum NR, Sonoda Y, Awtrey C, Hummer A, Venkatraman ES, et al.Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy. American Journal of Obstetrics and Gynecology 2004;191(4):1138-45. [PUBMED: 15507933 ]
20. Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 2009;115(6):1234-44. [MEDLINE: 19189349;: ]
21. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Journal of Gynaecologic Oncology 1998;62(2):103-8. [MEDLINE: 9600815]
22. Elattar A, Bryant A, Winter-Roach Brett A, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD007565.pub2;: CD007565]
23. Gerestein CG, van der Spek DW, Eijkemans MJ, Bakker J, Kooi GS, Burger CW. Prediction of residual disease after primary cytoreductive surgery for advanced-stage ovarian cancer: accuracy of clinical judgment. International Journal of Gynecological Cancer 2009;19(9):1511-5. [MEDLINE: 19955927]
24. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. International Agency for Research on Cancer. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. GLOBOCAN 2008 v2.0. Available from: http://globocan.iarc.fr accessed on 08/07/2013.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [PUBMED: 12111919]
26. Morrison J, Haldar K, Kehoe S, Lawrie TA. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD005343.pub3;: CD005343]
27. Munkarah AR, Coleman RL. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecologic Oncology 2004;95(2):273-80. [PUBMED: 15491746]
28. Ramirez I, Chon HS, Apte SM. The role of surgery in the management of epithelial ovarian cancer. Cancer Control 2011;18(1526-2359 (Electronic), 1073-2748 (Linking), 1):22-30.
29. Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC, et al.Secondary surgical cytoreduction for advanced ovarian carcinoma. New England Journal of Medicine 2004;351(24):2489-97.
30. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20(19):2865-84. [PUBMED: 11568945]
31. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012;62(1):10-29.
32. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al.Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. New England Journal of Medicine 2010;363:943-53. [MEDLINE: 20818904]
33. Vergote I, du Bois A, Amant F, Heitz F, Leunen K, Harter P. Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?. Gynecologic Oncology 2013;128(1):6-11. [PUBMED: 23006973]
34. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Medical Research Methodology 2006;6:9. [PUBMED: 16519814]
35. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al.QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine 2011;155(8):529-36. [PUBMED: 22007046]